These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11748775)

  • 41. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
    Marder SR; Davis JM; Chouinard G
    J Clin Psychiatry; 1997 Dec; 58(12):538-46. PubMed ID: 9448657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
    Rainer MK; Mucke HA; Krüger-Rainer C; Haushofer M; Kasper S
    CNS Drugs; 2004; 18(1):49-55. PubMed ID: 14731059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
    Fujikawa T; Takahashi T; Kinoshita A; Kajiyama H; Kurata A; Yamashita H; Yamawaki S
    Neuropsychobiology; 2004; 49(4):201-4. PubMed ID: 15118358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly.
    Laks J; Engelhardt E; Marinho V; Rozenthal M; Souza FC; Bacaltchuk J; Stoppe A; Ferreira RC; Bottino C; Scalco M
    Arq Neuropsiquiatr; 2001 Dec; 59(4):859-64. PubMed ID: 11733828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
    Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
    Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrapyramidal symptoms in patients treated with risperidone.
    Simpson GM; Lindenmayer JP
    J Clin Psychopharmacol; 1997 Jun; 17(3):194-201. PubMed ID: 9169965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral symptoms in dementia: community-based research.
    Auer SR; Monteiro IM; Reisberg B
    Int Psychogeriatr; 1996; 8 Suppl 3():363-6; discussion 381-2. PubMed ID: 9154589
    [No Abstract]   [Full Text] [Related]  

  • 53. Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial.
    Verhey FR; Verkaaik M; Lousberg R;
    Dement Geriatr Cogn Disord; 2006; 21(1):1-8. PubMed ID: 16244481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral disturbances in geropsychiatric inpatients across dementia types.
    Kunik ME; Huffman JC; Bharani N; Hillman SL; Molinari VA; Orengo CA
    J Geriatr Psychiatry Neurol; 2000; 13(1):49-52. PubMed ID: 10753008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients.
    Jeste DV; Lacro JP; Bailey A; Rockwell E; Harris MJ; Caligiuri MP
    J Am Geriatr Soc; 1999 Jun; 47(6):716-9. PubMed ID: 10366172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.